Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Contingent Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Contingent Liabilities ₹3.00 Cr₹3.00 Cr₹0.40 Cr₹15 Cr₹8.00 Cr

What is the latest Contingent Liabilities ratio of NATCO PHARMA ?

The latest Contingent Liabilities ratio of NATCO PHARMA is ₹3.00 Cr based on Mar2026 Consolidated results.
Year Contingent Liabilities
Mar2026₹3.00 Cr
Mar2025₹3.00 Cr
Mar2024₹0.40 Cr
Mar2023₹15 Cr
Mar2022₹8.00 Cr

How is Contingent Liabilities of NATCO PHARMA Trending?

Years Contingent Liabilities % Change
Mar2026 ₹3.00 Cr
0.00
Mar2025 ₹3.00 Cr
650.00
Mar2024 ₹0.40 Cr
-97.26
Mar2023 ₹15 Cr
82.50
Mar2022 ₹8.00 Cr -

Compare Contingent Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,598.4 Cr -2.8% -14.4% -3.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-2.8%

-14.4%

-3.2%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses